Atherogenic index of plasma is associated with major adverse cardiovascular events in patients with type 2 diabetes mellitus

[1] Beckman JA(2019)10. Cardiovascular disease and risk management: standards of medical care in diabetes—2019 Diabetes Care 42 S103-S123

[2] Paneni F(2013)Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part II Eur Heart J 34 2444-2452

[3] Cosentino F(2006)Relation between age and cardiovascular disease in men and women with diabetes compared with non-diabetic people: a population-based retrospective cohort study Lancet 368 29-36

[4] Creager MA(2010)Atherogenic dyslipidemia and diabetes mellitus: what’s new in the management arena? Vasc Health Risk Manag 6 665-669

[5] Booth GL(2014)Global estimates of diabetes prevalence for 2013 and projections for 2035 Diabetes Res Clin Pract 103 137-149

[6] Kapral MK(2017)Reducing the global burden of cardiovascular disease, part 2: prevention and treatment of cardiovascular disease Circ Res 121 695-710

[7] Fung K(2020)The atherogenic index of plasma plays an important role in predicting the prognosis of type 2 diabetic subjects undergoing percutaneous coronary intervention: results from an observational cohort study in China Cardiovasc Diabetol 19 23-588

[8] Tu JV(2001)The plasma parameter log (TG/HDL-C) as an atherogenic index: correlation with lipoprotein particle size and esterification rate in apoB-lipoprotein-depleted plasma (FER(HDL)) Clin Biochem 34 583-294

[9] Kumar A(2019)Atherogenic index of plasma: novel predictive biomarker for cardiovascular illnesses Arch Med Res 50 285-1188

[10] Singh V(2004)Pioglitazone reduces atherogenic index of plasma in patients with type 2 diabetes Clin Chem 50 1184-186

[1] Beckman JA(2019)10. Cardiovascular disease and risk management: standards of medical care in diabetes—2019 Diabetes Care 42 S103-S123

[2] Paneni F(2013)Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part II Eur Heart J 34 2444-2452

[3] Cosentino F(2006)Relation between age and cardiovascular disease in men and women with diabetes compared with non-diabetic people: a population-based retrospective cohort study Lancet 368 29-36

[4] Creager MA(2010)Atherogenic dyslipidemia and diabetes mellitus: what’s new in the management arena? Vasc Health Risk Manag 6 665-669

[5] Booth GL(2014)Global estimates of diabetes prevalence for 2013 and projections for 2035 Diabetes Res Clin Pract 103 137-149

[6] Kapral MK(2017)Reducing the global burden of cardiovascular disease, part 2: prevention and treatment of cardiovascular disease Circ Res 121 695-710

[7] Fung K(2020)The atherogenic index of plasma plays an important role in predicting the prognosis of type 2 diabetic subjects undergoing percutaneous coronary intervention: results from an observational cohort study in China Cardiovasc Diabetol 19 23-588

[8] Tu JV(2001)The plasma parameter log (TG/HDL-C) as an atherogenic index: correlation with lipoprotein particle size and esterification rate in apoB-lipoprotein-depleted plasma (FER(HDL)) Clin Biochem 34 583-294

[9] Kumar A(2019)Atherogenic index of plasma: novel predictive biomarker for cardiovascular illnesses Arch Med Res 50 285-1188

[10] Singh V(2004)Pioglitazone reduces atherogenic index of plasma in patients with type 2 diabetes Clin Chem 50 1184-186